VKTX - Top Pharma Stocks Under $5
Pharmaceutical stocks were initially expected to be largely immune to the COVID-19 economic downturn. Drugmakers, after all, generally produce products that are essential to daily life.
However, the extreme social distancing that has become part and parcel of this unusual period has halted numerous clinical trials, shuttered scores of clinics across the country that patients depend on for lifesaving medicines, and forced hospitals nationwide to put off noncritical procedures in order to focus on the ongoing pandemic.
The net result is that several pharma stocks -- especially companies in the pre-revenue end of the spectrum -- have been absolutely blasted by the market during the month of March.